Barely Significant
← all excerpts

Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectors.

J Exp Clin Cancer Res · 2021 · PMC8299618 · PMID 34294133

Europe PMCDOI
1
hedged sentence
0.0004
closest p · 0.0× alpha
0.0004
boldest claim

The sentences

highly significantP = 0.0004actually significant
Conversely, the use of CL4-PNPs as a delivery vehicle for Cis-Pt, resulted in a highly significant inhibitory performance on tumor growth compared to free Cis-Pt ( P = 0.0004) and Cis-Pt@PNPs-SCR (P = 0.0009) (Fig. 6 a).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.